HORMONE THERAPY IN ADVANCED BREAST-CANCER - COMPARISON BETWEEN HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MAP) AND TAMOXIFEN (TMX)

被引：0
|
作者：
PANNUTI, F [1 ]
MARTONI, A [1 ]
FRUET, F [1 ]
CRICCA, A [1 ]
机构：
[1] MALPIGHI HOSP,BOLOGNA,ITALY
来源：
CANCER TREATMENT REPORTS | 1979年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1219 / 1219
页数：1
相关论文
共 50 条
  • [31] RANDOMIZED STUDY COMPARING TAMOXIFEN (TMX)-MEDROXYPROGESTERONE ACETATE (MPA) ALTERNATED VS MPA ALONE IN ADVANCED BREAST-CANCER
    SANCHIZ, F
    BELON, J
    CRUZHERNANDEZ, JJ
    NAVARRETE, A
    ALONSO, J
    DIAZFAES, JG
    LIZON, J
    BARON, MG
    ARANDA, E
    JIMENO, J
    MILLA, A
    ANTICANCER RESEARCH, 1986, 6 (03) : 372 - 372
  • [32] Adjuvant therapy with high-dose medroxyprogesterone acetate for operable breast cancer
    Koyama H.
    Breast Cancer, 1999, 6 (2) : 99 - 107
  • [33] COMBINATION OF TAMOXIFEN, AMINOGLUTETHIMIDE, DANAZOL AND MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    HARDY, JR
    POWLES, TJ
    JUDSON, IR
    SINNETT, HD
    ASHLEY, SE
    COOMBES, RC
    ELLIN, CL
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (07) : 824 - 827
  • [34] ADRENAL SUPPRESSION BY ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS
    VANVEELEN, H
    WILLEMSE, PHB
    SLEIJFER, DT
    PRATT, JJ
    SLUITER, WJ
    DOORENBOS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (02) : 83 - 86
  • [35] 5-FLUOROURACIL, ADRIAMYCIN AND CYCLOPHOSPHAMIDE COMBINED WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    LOPEZ, M
    DILAURO, L
    PERNO, CF
    PAPALDO, P
    BARDUAGNI, M
    BARDUAGNI, A
    TUMORI, 1983, 69 (06) : 545 - 551
  • [36] ORAL VERSUS IM ADMINISTRATION OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER
    BEEX, L
    BURGHOUTS, J
    VANTURNHOUT, J
    BREED, W
    HILLEN, H
    HOLDRINET, A
    BOETIUS, G
    HOOGENDOORN, G
    DOESBURG, W
    VERHULST, M
    MEULENBERG, P
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1151 - 1156
  • [37] MECHANISM OF ADRENAL SUPPRESSION BY HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS
    VANVEELEN, H
    WILLEMSE, PHB
    SLEIJFER, DT
    VANDERPLOEG, E
    SLUITER, WJ
    DOORENBOS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (02) : 167 - 170
  • [38] CHEMOTHERAPY WITH OR WITHOUT HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ESTROGEN-RECEPTOR-NEGATIVE ADVANCED BREAST-CANCER
    GUNDERSEN, S
    KVINNSLAND, S
    KLEPP, O
    LUND, E
    HANNISDAL, E
    HOST, H
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) : 390 - 394
  • [39] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [40] ALTERNATING SEQUENTIAL ENDOCRINE THERAPY - TAMOXIFEN AND MEDROXYPROGESTERONE ACETATE VERSUS TAMOXIFEN IN POSTMENOPAUSAL ADVANCED BREAST-CANCER PATIENTS
    BELTRAN, M
    ALONSO, MC
    OJEDA, MB
    IZQUIERDO, A
    FERRER, J
    PICO, C
    ANGLADA, L
    CATALAN, G
    BATISTEALENTORN, E
    TUSQUETS, I
    RIFA, J
    BALIL, AM
    ANNALS OF ONCOLOGY, 1991, 2 (07) : 495 - 499
12345